LUGPA: Hospital IMRT Expenditures are on the Rise

An analysis of data from a recent Government Accountability Office (GAO) report explains why there is no health policy advantage to limiting where patients can choose to receive radiation oncology services for prostate cancer, according to the Large Urology Group Practice Association (LUGPA), which conducted the analysis. To read more, please click on the link or PDF. Read Article.

This entry was posted in News. Bookmark the permalink.